LY2584702 25mg | Purity Not Available
Selleck Chemicals
LY2584702 is a selective, ATP-competitive p70S6K inhibitor with IC50 of 4 nM.
More Information Supplier PageLY2584702 is a selective, ATP-competitive p70S6K inhibitor with IC50 of 4 nM.
More Information Supplier PageObeticholic Acid (INT-747) is a potent and selective farnesoid X receptor (FXR) agonist with EC50 of 99 nM. Obeticholic Acid inhibits autophagy. Phase 3.
More Information Supplier PageKartogenin (KGN) is an activator of the smad4/smad5 pathway, and promotes the selective differentiation of multipotent mesenchymal stem cells into chondrocytes.
More Information Supplier PageKartogenin (KGN) is an activator of the smad4/smad5 pathway, and promotes the selective differentiation of multipotent mesenchymal stem cells into chondrocytes.
More Information Supplier PageDefactinib (VS-6063, PF-04554878) is a selective, and orally active FAK inhibitor. Phase 2.
More Information Supplier PageDefactinib (VS-6063, PF-04554878) is a selective, and orally active FAK inhibitor. Phase 2.
More Information Supplier PageDefactinib (VS-6063, PF-04554878) is a selective, and orally active FAK inhibitor. Phase 2.
More Information Supplier PageObeticholic Acid (INT-747) is a potent and selective farnesoid X receptor (FXR) agonist with EC50 of 99 nM. Obeticholic Acid inhibits autophagy. Phase 3.
More Information Supplier PageObeticholic Acid (INT-747) is a potent and selective farnesoid X receptor (FXR) agonist with EC50 of 99 nM. Obeticholic Acid inhibits autophagy. Phase 3.
More Information Supplier PageGSK2578215A is a potent and selective LRRK2 kinase inhibitor with IC50 of 8.9 nM and 10.9 nM for LRRK2 (G2019S) and LRRK2 (WT), respectively.
More Information Supplier Page